Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 AUD | -25.00% | -25.00% | -14.29% |
25/03 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
14/03 | Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-14.29% | 8.37M | |
+29.31% | 48.16B | |
-0.58% | 41.73B | |
+43.74% | 41.03B | |
-5.31% | 28.77B | |
+10.93% | 25.59B | |
-21.97% | 18.96B | |
+8.31% | 12.92B | |
+27.13% | 12.03B | |
-3.20% | 11.77B |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited
- Avecho Biotechnology Secures Ethics Approval for Phase 3 Insomnia Trial